Cognition Therapeutics is currently prioritizing zervimesine for DLB psychosis. This is after the FDA's feedback gave their planned pivotal program a clearer path. Basically, DLB psychosis has no approved therapy, and zervimesine is a promising oral once-daily drug that already has interesting Phase 2 data. CGTX's SHIMMER trial was a good start, but their next trial must confirm longer-lasting hallucination and delusion benefits.
Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are likely to aid Zacks Audio Video Production industry participants like SONY, DLB and SONO.
Dolby Laboratories, Inc. (DLB) Presents at 2026 Baird Global Consumer, Technology & Services Conference Transcript
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 484 | $35,026.97 | $24,076.58 | -$10,950.39 | -31.26% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 68 | $5,128.5 | $3,380.96 | -$1,747.54 | -34.08% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 38,480 | $2.31M | $1.91M | -$402,500.8 | -17.42% |
| YA Yinka Akinsola Blue Trust Inc. | 849 | $65,149.67 | $42,144.36 | -$23,005.31 | -35.31% |
Jeff Ameen Spire Wealth Management | 19 | $1,607.65 | $921.69 | -$685.96 | -42.67% |
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| PS Patrick Sholl Barrington Research | 158.95 | $9,776.15 | $7,852.31 | -$1,923.84 | -19.68% |
| Entertainment Industry | Communication Services Sector | Kevin J. Yeaman CEO | NYSE Exchange | 25659T107 CUSIP |
| US Country | 2,080 Employees | 12 May 2026 Last Dividend | - Last Split | 17 Feb 2005 IPO Date |
Dolby Laboratories, Inc. stands out as a pioneering company in the world of audio and imaging technologies, significantly enhancing entertainment experiences across various platforms. Founded in 1965 and based in San Francisco, California, Dolby Laboratories has revolutionized the way we experience sound and visuals in cinemas, on digital television transmissions, mobile devices, over-the-top (OTT) video and music services, home entertainment systems, and even in automobiles. The firm is renowned for developing and licensing an array of audio technologies that have become integral to media applications worldwide. Additionally, it has made notable strides in digital imaging, offering solutions that have raised the bar for visual presentation in the entertainment industry.
Beyond these technologies, Dolby Laboratories also provides a wide range of products and services catered to the cinema, television, broadcast, communication, and entertainment sectors. These offerings include digital cinema servers, cinema processors, amplifiers, loudspeakers, as well as audio and imaging hardware and software products. The company also supports the entertainment industry with 3-D glasses, kits, and various services aimed at enhancing theatrical and television production for cinema exhibitions, broadcasts, and home entertainment. Dolby serves a diverse clientele, including film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers, distributing its products and services directly to end users or through a network of dealers and distributors globally.